The company’s exit from the U.K. market would spark a major index re-weighting, given AstraZeneca is the most valuable business listed on London’s FTSE 100. AstraZeneca’s market cap was £161.2 billion …
London stock market could weather its biggest blow yet if AstraZeneca exits
view original post